Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
Switzerland
/
Pharmaceuticals & Biotech
/
Novartis
Create a narrative
Novartis Community
SWX:NOVN Community
1
Narratives
written by author
0
Comments
on narratives written by author
134
Fair Values set
on narratives written by author
Community Investing Ideas
Novartis
Popular
Undervalued
Overvalued
Novartis
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
China Expansion And Advanced Therapies Will Drive Future Upside
Key Takeaways Strong demand for innovative therapies and expansion in emerging markets support growth, while operational efficiency boosts margins and long-term profitability. Advancements in advanced therapies and substantial shareholder returns position the company for accelerated earnings and enhanced equity performance.
View narrative
CHF 97.49
FV
0.8% undervalued
intrinsic discount
2.39%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
84
users have followed this narrative
Updated
narrative